Literature DB >> 10797095

High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates.

J Oteo1, B Aracil, J I Alós, J L Gómez-Garcés.   

Abstract

Susceptibility to anti-anaerobic agents in the Bacteroides fragilis group varies according to the geographical region studied. In recent years there has been a reduction in the susceptibility of such isolates, particularly to antibiotics such as clindamycin and cefoxitin. The antimicrobial susceptibilities of 100 isolates of the B. fragilis group isolated in 1998 from faecal samples of healthy people to clindamycin and five other anti-anaerobic agents were determined. Meropenem, metronidazole and trovafloxacin showed excellent activity against all isolates. The efficacy of cefoxitin was low, with only 46% of isolates susceptible. A high prevalence of resistance to clindamycin (49% of isolates) was observed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797095     DOI: 10.1093/jac/45.5.691

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.

Authors:  Anastasia Katsandri; Joseph Papaparaskevas; Angeliki Pantazatou; Georgios L Petrikkos; Georgios Thomopoulos; Dimitra P Houhoula; Athina Avlamis
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

2.  In vitro susceptibility to selected antibiotics in bacteria of the Bacteroides fragilis group.

Authors:  D Chmelar
Journal:  Folia Microbiol (Praha)       Date:  2009-10-14       Impact factor: 2.099

3.  In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.

Authors:  Kenneth E Aldridge; Megan O'Brien
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.

Authors:  Reiner Schaumann; Matthias Funke; Eva Janssen; Arne C Rodloff
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

5.  Do antimicrobial susceptibility patterns of colonic isolates of Bacteroides species change after antibiotic prophylaxis with cefoxitine during elective abdominal surgery?

Authors:  Nurver Ulger Toprak; Bahadir M Güllüoğlu; Ozlem Cakici; M Levhi Akin; Pakize Demirkalem; Tuncay Celenk; Güner Söyletir
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

6.  Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.

Authors:  K E Aldridge; D Ashcraft; K Cambre; C L Pierson; S G Jenkins; J E Rosenblatt
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

7.  Bacteroides fragilis group: trends in resistance.

Authors:  Manfred Fille; Monica Mango; Matthias Lechner; Reiner Schaumann
Journal:  Curr Microbiol       Date:  2006-01-31       Impact factor: 2.188

Review 8.  Pyogenic and amebic liver abscesses.

Authors:  Jayde E Kurland; Oscar S Brann
Journal:  Curr Gastroenterol Rep       Date:  2004-08

Review 9.  Pelvic surgical site infections in gynecologic surgery.

Authors:  Mark P Lachiewicz; Laura J Moulton; Oluwatosin Jaiyeoba
Journal:  Infect Dis Obstet Gynecol       Date:  2015-02-18

10.  Prevalence and antibiotic susceptibility of Bacteroides fragilis group isolated from stool samples in North Lebanon.

Authors:  Mariam Yehya; Monzer Hamze; Hassan Mallat; Fouad Dabbousi
Journal:  Braz J Microbiol       Date:  2014-01-15       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.